Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | E2F7 | Human | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | EXP | | 6480464 | o and p'-DDT results in increased expression of E2F7 mRNA | CTD | PMID:18204070 | E2F7 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of E2F7 mRNA | CTD | PMID:30723492 | E2F7 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of E2F7 mRNA | CTD | PMID:19167446 | E2F7 | Human | 17beta-estradiol | multiple interactions | ISO | E2f7 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F7 mRNA | CTD | PMID:32741896 | E2F7 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of E2F7 mRNA | CTD | PMID:30165855 | E2F7 | Human | 17beta-estradiol | increases activity | EXP | | 6480464 | Estradiol results in increased activity of E2F7 protein | CTD | PMID:27592001 | E2F7 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | E2f7 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F7 mRNA | CTD | PMID:32741896 | E2F7 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:20638727 | E2F7 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | E2f7 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | E2F7 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | E2f7 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | E2F7 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | E2f7 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of E2F7 mRNA | CTD | PMID:24058054 | E2F7 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of E2F7 mRNA | CTD | PMID:32109520 and PMID:33387578 | E2F7 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of E2F7 mRNA | CTD | PMID:30096437 | E2F7 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of E2F7 mRNA | CTD | PMID:26159488 | E2F7 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of E2F7 mRNA | CTD | PMID:22574217 | E2F7 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | E2f7 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of E2F7 mRNA | CTD | PMID:21570461 | E2F7 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of E2F7 mRNA | CTD | PMID:21802500 | E2F7 | Human | 2,4-diaminotoluene | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | 2 and 4-diaminotoluene results in increased expression of E2F7 mRNA | CTD | PMID:20713471 | E2F7 | Human | 2-butoxyethanol | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of E2F7 mRNA | CTD | PMID:19812364 | E2F7 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of E2F7 mRNA | CTD | PMID:37199045 | E2F7 | Human | 3-methylcholanthrene | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of E2F7 mRNA | CTD | PMID:20713471 | E2F7 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Fenretinide results in increased expression of E2F7 mRNA | CTD | PMID:28973697 | E2F7 | Human | acetamide | increases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of E2F7 mRNA | CTD | PMID:31881176 | E2F7 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of E2F7 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of E2F7 mRNA | CTD | PMID:32699268 | E2F7 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of E2F7 mRNA | CTD | PMID:32763439 | E2F7 | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of E2F7 protein | CTD | PMID:20106945 | E2F7 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of E2F7 promoter | CTD | PMID:31555880 | E2F7 | Human | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of E2F7 mRNA | CTD | PMID:21632981 more ... | E2F7 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of E2F7 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of E2F7 mRNA | CTD | PMID:32699268 | E2F7 | Human | antimycin A | decreases expression | ISO | E2f7 (Mus musculus) | 6480464 | Antimycin A results in decreased expression of E2F7 mRNA | CTD | PMID:19304788 | E2F7 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of E2F7 mRNA | CTD | PMID:33212167 | E2F7 | Human | arsane | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of E2F7 mRNA | CTD | PMID:19945496 | E2F7 | Human | arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of E2F7 mRNA | CTD | PMID:19945496 | E2F7 | Human | arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to E2F7 mRNA] | CTD | PMID:32406909 | E2F7 | Human | atrazine | affects methylation | ISO | E2f7 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of E2F7 gene | CTD | PMID:35440735 | E2F7 | Human | azathioprine | decreases expression | EXP | | 6480464 | Azathioprine results in decreased expression of E2F7 mRNA | CTD | PMID:22623647 | E2F7 | Human | benzo[a]pyrene | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of E2F7 mRNA | CTD | PMID:20713471 | E2F7 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of E2F7 promoter | CTD | PMID:31555880 | E2F7 | Human | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of E2F7 mRNA | CTD | PMID:20064835 more ... | E2F7 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of E2F7 mRNA | CTD | PMID:21802500 | E2F7 | Human | benzo[b]fluoranthene | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of E2F7 mRNA | CTD | PMID:26377693 | E2F7 | Human | bisphenol A | decreases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of E2F7 mRNA | CTD | PMID:25181051 | E2F7 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of E2F7 mRNA | CTD | PMID:33670352 | E2F7 | Human | bisphenol F | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | bisphenol F results in increased expression of E2F7 mRNA | CTD | PMID:30951980 | E2F7 | Human | bromobenzene | increases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | bromobenzene results in increased expression of E2F7 mRNA | CTD | PMID:32479839 | E2F7 | Human | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of E2F7 mRNA | CTD | PMID:21120746 | E2F7 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of E2F7 protein | CTD | PMID:35688186 | E2F7 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of E2F7 mRNA | CTD | PMID:21592394 | E2F7 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of E2F7 mRNA | CTD | PMID:21592394 | E2F7 | Human | cannabidiol | increases expression | EXP | | 6480464 | Cannabidiol results in increased expression of E2F7 mRNA | CTD | PMID:36519830 | E2F7 | Human | carbon nanotube | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | E2F7 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to E2F7 gene] | CTD | PMID:28238834 | E2F7 | Human | chloroprene | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Chloroprene results in increased expression of E2F7 mRNA | CTD | PMID:23125180 | E2F7 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of E2F7 mRNA | CTD | PMID:27392435 more ... | E2F7 | Human | cobalt atom | multiple interactions | EXP | | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of E2F7 mRNA | CTD | PMID:18078969 | E2F7 | Human | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of E2F7 mRNA | CTD | PMID:20971185 | E2F7 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of E2F7 mRNA | CTD | PMID:20971185 | E2F7 | Human | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of E2F7 mRNA | CTD | PMID:19167446 | E2F7 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | E2F7 | Human | CU-O LINKAGE | decreases expression | EXP | | 6480464 | cupric oxide results in decreased expression of E2F7 mRNA | CTD | PMID:22077320 | E2F7 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of E2F7 mRNA | CTD | PMID:21632981 | E2F7 | Human | cyclosporin A | affects expression | EXP | | 6480464 | Cyclosporine affects the expression of E2F7 mRNA | CTD | PMID:20106945 and PMID:25562108 | E2F7 | Human | dibenz[a,h]anthracene | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | E2F7 | Human | dibutyl phthalate | decreases expression | ISO | E2f7 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of E2F7 mRNA | CTD | PMID:21266533 | E2F7 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of E2F7 mRNA | CTD | PMID:28302478 | E2F7 | Human | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of E2F7 mRNA | CTD | PMID:26516004 | E2F7 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of E2F7 mRNA | CTD | PMID:29803840 | E2F7 | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of E2F7 mRNA | CTD | PMID:30031762 | E2F7 | Human | endosulfan | multiple interactions | EXP | | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of E2F7 mRNA | CTD | PMID:26159488 | E2F7 | Human | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA | CTD | PMID:19167446 | E2F7 | Human | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of E2F7 mRNA | CTD | PMID:23649840 | E2F7 | Human | folic acid | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Folic Acid results in increased expression of E2F7 mRNA | CTD | PMID:25629700 | E2F7 | Human | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of E2F7 mRNA | CTD | PMID:23649840 | E2F7 | Human | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of E2F7 protein | CTD | PMID:37730182 | E2F7 | Human | gallic acid | decreases expression | EXP | | 6480464 | Gallic Acid results in decreased expression of E2F7 mRNA | CTD | PMID:34408198 | E2F7 | Human | gentamycin | decreases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of E2F7 mRNA | CTD | PMID:33387578 | E2F7 | Human | harmine | increases expression | EXP | | 6480464 | Harmine results in increased expression of E2F7 mRNA | CTD | PMID:25751815 | E2F7 | Human | Lasiocarpine | multiple interactions | EXP | | 6480464 | [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of E2F7 mRNA | CTD | PMID:33884520 | E2F7 | Human | Lasiocarpine | increases expression | EXP | | 6480464 | lasiocarpine results in increased expression of E2F7 mRNA | CTD | PMID:32234424 | E2F7 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of E2F7 mRNA | CTD | PMID:28903495 | E2F7 | Human | MeIQx | increases expression | EXP | | 6480464 | 2-amino-3 more ... | CTD | PMID:20816883 | E2F7 | Human | methoxychlor | affects methylation | ISO | E2f7 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of E2F7 gene | CTD | PMID:35440735 | E2F7 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of E2F7 mRNA | CTD | PMID:23649840 | E2F7 | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of E2F7 mRNA | CTD | PMID:27188386 | E2F7 | Human | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of E2F7 mRNA | CTD | PMID:24810058 | E2F7 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of E2F7 mRNA | CTD | PMID:25583101 | E2F7 | Human | niclosamide | decreases expression | EXP | | 6480464 | Niclosamide results in decreased expression of E2F7 mRNA | CTD | PMID:36318118 | E2F7 | Human | ozone | multiple interactions | ISO | E2f7 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of E2F7 mRNA more ... | CTD | PMID:25658374 more ... | E2F7 | Human | ozone | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Ozone results in increased expression of E2F7 mRNA | CTD | PMID:33026818 | E2F7 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of E2F7 mRNA more ... | CTD | PMID:32699268 | E2F7 | Human | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of E2F7 mRNA | CTD | PMID:20732408 | E2F7 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of E2F7 mRNA | CTD | PMID:22230336 and PMID:29067470 | E2F7 | Human | paracetamol | increases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of E2F7 mRNA | CTD | PMID:20732408 and PMID:33387578 | E2F7 | Human | PCB138 | multiple interactions | ISO | E2f7 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | E2F7 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of E2F7 mRNA | CTD | PMID:36326898 | E2F7 | Human | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of E2F7 mRNA | CTD | PMID:19084549 | E2F7 | Human | phenobarbital | affects expression | ISO | E2f7 (Mus musculus) | 6480464 | Phenobarbital affects the expression of E2F7 mRNA | CTD | PMID:23091169 | E2F7 | Human | phosphoramide mustard | increases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | phosphoramide mustard results in increased expression of E2F7 protein | CTD | PMID:26708502 | E2F7 | Human | picoxystrobin | increases expression | EXP | | 6480464 | picoxystrobin results in increased expression of E2F7 mRNA | CTD | PMID:33512557 | E2F7 | Human | propanal | decreases expression | EXP | | 6480464 | propionaldehyde results in decreased expression of E2F7 mRNA | CTD | PMID:26079696 | E2F7 | Human | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of E2F7 mRNA | CTD | PMID:21632981 | E2F7 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of E2F7 mRNA | CTD | PMID:19167446 | E2F7 | Human | rotenone | decreases expression | ISO | E2f7 (Mus musculus) | 6480464 | Rotenone results in decreased expression of E2F7 mRNA | CTD | PMID:19304788 | E2F7 | Human | silicon dioxide | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of E2F7 mRNA | CTD | PMID:29341224 | E2F7 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of E2F7 mRNA | CTD | PMID:29301061 | E2F7 | Human | sodium arsenite | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of E2F7 mRNA | CTD | PMID:37682722 | E2F7 | Human | sotorasib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of E2F7 mRNA | CTD | PMID:36139627 | E2F7 | Human | succimer | multiple interactions | ISO | E2f7 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F7 mRNA | CTD | PMID:21641980 | E2F7 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of E2F7 mRNA | CTD | PMID:31533062 | E2F7 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of E2F7 mRNA | CTD | PMID:31758290 | E2F7 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of E2F7 mRNA | CTD | PMID:21592394 | E2F7 | Human | testosterone | multiple interactions | ISO | E2f7 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of E2F7 mRNA | CTD | PMID:32741896 | E2F7 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of E2F7 mRNA | CTD | PMID:21592394 | E2F7 | Human | tetrachloromethane | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of E2F7 mRNA | CTD | PMID:17484886 | E2F7 | Human | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of E2F7 mRNA | CTD | PMID:22378314 | E2F7 | Human | thioacetamide | increases expression | ISO | E2f7 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of E2F7 mRNA | CTD | PMID:34492290 | E2F7 | Human | titanium dioxide | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of E2F7 mRNA | CTD | PMID:23557971 and PMID:29264374 | E2F7 | Human | trametinib | multiple interactions | EXP | | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of E2F7 mRNA | CTD | PMID:36139627 | E2F7 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of E2F7 mRNA | CTD | PMID:30510588 | E2F7 | Human | trimellitic anhydride | increases expression | ISO | E2f7 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of E2F7 mRNA | CTD | PMID:19042947 | E2F7 | Human | triptonide | affects expression | ISO | E2f7 (Mus musculus) | 6480464 | triptonide affects the expression of E2F7 mRNA | CTD | PMID:33045310 | E2F7 | Human | trovafloxacin | decreases expression | ISO | E2f7 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of E2F7 mRNA | CTD | PMID:35537566 | E2F7 | Human | tungsten | decreases expression | ISO | E2f7 (Mus musculus) | 6480464 | Tungsten results in decreased expression of E2F7 mRNA | CTD | PMID:30912803 | E2F7 | Human | Tungsten carbide | multiple interactions | EXP | | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of E2F7 mRNA | CTD | PMID:18078969 | E2F7 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of E2F7 mRNA | CTD | PMID:28818685 | |